The geriatric populace and unfortunate way of life is one of the main factor in charge of diabetes among the diabetic patients. As per WHO, the significant area of the world is analyzed from sort 2 diabetes to a substantial degree. This can be another significant factor decidedly adding to the development of this market in not so distant future. Different programming organizations are thinking of new strategy to oversee and control diabetes through applications, this can be another key factor activating development of the worldwide market for man-made brainpower in diabetes the board in coming years. Additionally, expanding selection of cell phones among the general population enables the organizations to create application for overseeing and controlling diabetes through explicit application.

The world of startups is constantly moving and evolving. With the exponential growth of deep learning research and technologies in recent years, innovative new companies are often funded, acquired and transformed from startups to industry leaders extremely quickly. MedicSen is a startup focused on developing non-invasive treatments for diabetes, utilising connected devices, machine learning algorithms and a cloud platform to revolutionise diabetic patient's lives. By applying artificial intelligence and sensor tech, the algorithm can predict future glucose levels and risky events and, according to that, give the patient medical advice and instructions for the amount of insulin they need and at what time. Since we first met the MedicSen team at the 2016 Deep Learning in Healthcare Summit in London, their team has grown and their mission has evolved.